The efficacy and safety of agomelatine, sertraline, and escitalopram for senile post-stroke depression: A randomized double-blind placebo-controlled trial-Reference-Cited by-同舟云学术

The efficacy and safety of agomelatine, sertraline, and escitalopram for senile post-stroke depression: A randomized double-blind placebo-controlled trial

Published:2021-06 Issue: Volume:205 Page:106651
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Yao Xian-Wei,Li Yan-Lan,Yu Zhi-Jun,Mo Cui-Ying,Pan Hong-Shan,Li Chun-Yang

Funder

Dongguan Science and Technology Bureau

Foshan Municipal Science and Technology Office

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Surgery

Reference57 articles.

1. Time to stroke: a Western Trauma Association multicenter study of blunt cerebrovascular injuries;Burlew;J. Trauma Acute Care Surg.,2018

2. A conceptual model of treatment burden and patient capacity in stroke;Gallacher;BMC Fam. Pr.,2018

3. Managing cognitive impairment following stroke: protocol for a systematic review of non-randomised controlled studies of psychological interventions;Merriman;BMJ Open,2018

4. Post-stroke depression: a review;Robinson;Am. J. Psychiatr.,2016

5. Comparison of poststroke depression between acute ischemic and hemorrhagic stroke patients;Zeng;Int J. Geriatr. Psychiatr.,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Repetitive Transcranial Magnetic Stimulation on Post-Stroke Comorbid Cognitive Impairment and Depression: A Randomized Controlled Trial;Journal of Alzheimer's Disease;2024-08-27

2. The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial;BMC Psychiatry;2024-05-15

3. Bidirectional associations between mental disorders, antidepressants and cardiovascular disease;BMJ Mental Health;2024-01

4. A comprehensive overview of post-stroke depression treatment options;International Clinical Psychopharmacology;2023-12-27

5. Efficacy and safety of agomelatine in the treatment of patients with depressive disorder: A meta-analysis;Medicine;2023-11-10